IL-1β (interleukin-1β) stimulates the production and release of multiple cytokines and chemokines by human preadipocytes by Alomar, Suliman Yousef et al.
 “This is an Accepted Manuscript of an article published by Taylor & Francis in Archives of 
Physiology and Biochemistry on 16th March 2016, available at 
http://www.tandfonline.com/doi/full/10.3109/13813455.2016.1156706.” 
  
1  
  
REVISED  
    
  
IL-1β (interleukin-1β) stimulates the production and release of 
multiple cytokines and chemokines by human preadipocytes  
  
Suliman  Y.  Alomar1,  Alessandra  Gentili2,  Mohamed  S.  Zaibi2,  Malgorzata  A.  
Kępczyńska2andPaul Trayhurn1,2,3*  
  
1Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia;2Clore Laboratory, 
University of Buckingham, Buckingham, United Kingdom;3Obesity Biology Unit, University of Liverpool, Duncan 
Building, Liverpool, United Kingdom  
  
 
  
RUNNING TITLE:  IL-1β stimulates cytokine and chemokine release by preadipocytes  
Keywords:    Adipocytes, adipose tissue, gene expression, inflammation, protein arrays  
  
  
*Correspondence should be addressed to:  
  
Professor Paul Trayhurn, FRSE  
Clore Laboratory  
University of Buckingham   
Hunter Street  
Buckingham MK18 1EG, UK  
  
Email: p.trayhurn@liverpool.ac.uk  
Fax:  +44 1280 820135  
  
    
2  
  
Abstract  
The effect of IL-1β on cytokine and chemokine production by human preadipocytes has been 
examined. Preadipocytes were incubated with IL-1β and cytokine and chemokine release measured 
at 24 h by protein arrays, while the expression of cytokine/chemokine genes was assessed by qPCR 
at 4 and 24 h. IL-1β stimulated the secretion of multiple cytokines/chemokines, including IL-6, 
IL-8, IL-10, IL-13, MCP-4, TNFα and IP-10. IL-10 was not released by un-stimulated 
preadipocytes, while IL-6 exhibited the greatest response to IL-1β (453-fold increase). IL-16 and 
IL-12p40 did not respond to IL-1β. qPCR demonstrated that IL1β markedly stimulated CCL3, 
CSF3 and CXCL10expression at 4 h (>900-fold mRNA increase). A time-course indicated that 
while CCL13 (encoding MCP-4) exhibited minimal basal expression in preadipocytes, expression 
increased progressively following differentiation. Human preadipocytes are highly sensitive to IL-
1β, the cytokine stimulating a major inflammatory response in these cells similar to that in mature 
adipocytes.  
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Introduction  
White adipose tissue, the expansion of which defines obesity, is composed of multiple cell types. 
The signature cell of the tissue, the mature adipocyte,both stores triacylglycerols and is a major 
endocrine and secretory cell. Multiple cytokines and chemokines are among the diverse range of 
proteins, or adipokines, released by white adipocytes, particularly when tissue mass increases with 
obesity (Frühbeck et al., 2001; Trayhurn et al., 2001; Rajala et al., 2004; Meijer et al., 2011; Trayhurn, 
2013). The secretion of these, and other, inflammation-related factors is considered to underpin 
the development of the major obesity-associated diseases, including insulin resistance and the 
metabolic syndrome (Hotamisligil, 2006; Rosen & Spiegelman, 2006; Bluher, 2009). Macrophages 
and other immune cells are key contributors to the inflammatory state of adipose tissue in obesity, 
this involving cross-talk between them and adipocytes (Weisberg et al., 2003; Xu et al., 2003; Pond, 
2005; Bertola et al., 2012). Secretions from macrophages have been shown to induce an extensive 
pro-inflammatory response in white fat cells (O’Hara et al., 2009; Meijer et al., 2011).  
Preadipocytes, the precursor cells of adipocytes, also have the potential to contribute to 
inflammation in white adipose tissue depots. Indeed, a substantial inflammatory response is 
induced following exposure to agents such as lipopolysaccharide (Chung et al., 2006; 
PoulainGodefroy & Froguel, 2007; Meijer et al., 2011) and to secreted factors from macrophages 
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(Lacasa et al., 2007; Keophiphath et al., 2009; Gao & Bing, 2011; O’Hara et al., 2012). The effect of 
macrophage secretions involvesthe stimulation of the expression of several hundred genes, 
particularly those associated with inflammation, macrophage infiltration, lipid accumulation and 
the extracellular matrix, and reflect an overall pro-inflammatory and pro-fibrotic response (Lacasa 
et al., 2007; Keophiphath et al., 2009; O’Hara et al., 2012). One of the majorsignals from  
macrophages, IL-1has been shown to be a key factor in the upregulation of IL-6 
expressionand release in human preadipocytes(O’Hara et al., 2012). Similarly, IL-1has been 
found to stimulate the expression and release of specific matrix metalloproteinases (MMP1 and 
MMP3) in the same cells, this involving MAPK signalling (Gao & Bing, 2011).  
These observations raise the possibility that IL-1β has extensive effects on the release of 
inflammation-relatedfactorsbypreadipocytes, as we have recently demonstrated in differentiated 
human adipocytes (Alomar et al., 2015). In the present study, we have examined the extent to which 
IL-1β directly stimulates the production and secretion of cytokines and chemokines by human 
preadipocytes. Panels of protein arrays have been used to measure the release of these factors into 
the culture medium. The effect of IL-1β on the expression of selected cytokine/chemokine genes 
was also examined. The results are consistent with the view that preadipocytes are important 
inflammatory cells in white adipose tissue and that like adipocytes they are highly responsive to IL-
1β.   
  
Materials and Methods  
Cell culture  
Human fibroblastic preadipocytes (Ref C-12730, Lot 395Z024) were obtained from Promocell 
(Germany) together with the appropriate cell culture media. They were isolated from the 
subcutaneous adipose tissue of a female Caucasian donor, aged 44 years, with a BMI of 22. On 
receipt, the cells were plated (5000 cells/cm2) in 12-well plates and incubated in a proprietary 
growth medium (C-27410) containing 5% fetal calf serum, hydrocortisone (1µg/ml), heparin (90 
µg/ml) and epidermal growth factor (10 ng/ml). The preadipocytes were grown to confluence (6-
7 days) at which point they were used for experiments; the cells did not stain for lipid and in 
previous studies we have confirmed that, as expected, they do not express markers of adipocyte 
differentiation such as leptin.   
In the main experiments, the preadipocytes were incubated with human recombinant IL1β 
(Sigma, UK) for either 4 or 24 h, to determine the acute and long-term effects of the cytokine, as 
in our previous studies on mature adipocytes (Alomar et al., 2015). The dose of IL1β used (2 ng/ml) 
was the same as previously, and is based on studies which indicate a maximal, or near-maximal, 
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response in human fat cells (Gao & Bing, 2011). Control preadipocytes were incubated without 
IL-1β. At the end of the incubation period the medium was removed, frozen, and stored at -20oC 
until analysis. The preadipocytes were immediately washed with ice-cold PBS, frozen in TRI-
Reagent (Sigma, UK) and stored at -80oC. Six sets of cells were used for each of the experimental 
groups.  
In some cases, the preadipocytes were induced to differentiate by transfer for 72 h to a 
differentiation medium containing insulin (0.5 µg/ml), dexamethasone (400 ng/ml), IBMX (44 
µg/ml) thyroxine (9 ng/ml) and ciglitazone (3 µg/ml), followed by Adipocyte Nutrition Medium, 
exactly according to the protocol described recently (Alomar et al., 2015). Some of the cells were 
taken every two days following the induction of differentiation and processed as for the 
preadipocytes prior to storage at -80oC. The medium was also taken and frozen at -20oC until 
analysis.   
Protein arrays  
MSD assay kits (MesoScale Discovery, USA) were used to measure the release of cytokines and 
chemokines into the cell culture medium (Alomar et al., 2015). These sandwich ELISAs enable 
protein targets to be measured rapidly in small sample volumes. The following ten multi-spot plates 
were employed:  V-PLEX Cytokine Panel 1 Human Kit (Ref : K15050D), V-PLEX Chemokine 
Panel 1 Human Kit (REF : K15047D) and V-PLEX Pro-inflammatory Panel 1 Human Kit (Ref : 
K15049D). The plates were pre-coated with capture antibodies on independent, well-defined spots 
and the assay was performed according to the manufacturer’s instructions.  
Proprietary Meso Scale software was used to analyse the data. The lowest limit of detection 
in the arrays was 0.01 pg/ml and this was for IL-18.  
RNA extraction  
Preadipocytes were homogenised in the TRI-Reagent in which they had been stored and total RNA 
extracted using RNeasy Micro Kits (QIAGEN, UK). The quantify and purity of the RNA was 
measured with a UV-Vis spectrophotometer (NanoDropTM 1000, USA). The average absorbance 
ratios (260/280 nm and 260/230 nm) were close to 2.0 for all samples. The integrity of the isolated 
RNA was analysed with an Agilent 2100 Bioanalyser (Agilent Technologies, Germany), and the 
Integrity Number for RNA samples was approximately 10.   
Real-time PCR  
Total RNA was DNAse-treated with a TURBO-DNA-freeTM kit (Ambion, Life TechnologiesTM, 
USA) and 1µg was reverse transcribed using Taqman® reverse transcription reagents (InvitrogenTM, 
Applied Biosystems, UK).Real-time PCR was performed with15-30ng of cDNA, in duplicates or 
triplicates, usingGene Expression Master Mix and predesigned TaqMan® Gene Assays consisting 
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of specific Taqman® probes (Applied Biosystems®, Life TechnologiesTM, USA). Probes were 
obtained for the humanIL7, CCL3, CCL11, CCL13, CXCL10, CSF2 andCSF3 genes, 
andforACTB (-actin) as the control gene. PCR reactions were set up in duplex format where the 
FAM-labelled Taqman® probe for the gene of interest was mixed with the VIClabelled Taqman® 
probe for the control gene (ACTB).   
PCR amplification was performed using a real-time PCR detection system (ABI 
StepOneplusTM, Applied Biosystems®, Life TechnologiesTM, USA) with a two-step thermal cycling: 
95C for 10 min, followed by 40 cycles of 95C for 15 sec and 60C for 1 min. All procedures 
were carried out in accordance with the manufacturer’s recommendation. The data were analysed 
by the comparative 2-∆∆Ct method and expressed as fold-changes in the target gene normalized to 
the endogenous reference gene (ACTB) in IL-1β treated adipocytes and related to the expression 
of the untreated samples (normalised such that the mRNA level in the untreated cells = 1.0).  
   
Statistical analysis  
The statistical significance of differences between IL-1β treated and control cells in the protein 
array studies was assessed using Student’s ttest.ANOVA with a Bonferroni post-test for selected 
columns was used in the case of the gene expression data.  
  
Results  
Protein release  
Preadipocytes were taken immediately before they would normally be induced to differentiate into 
adipocytes, and incubated with IL-1β for 4 or 24 h. The medium was used from the cells incubated 
for 24 h to measure the release of cytokines and chemokines so as to maximise the possibility that 
sufficient protein was present for analysis. Three different arrays were used such that in total the 
release of >20 proteins was investigated. All but one of the proteins on the arrayswas detected in 
the culture medium of untreated cells, indicating that eachis a normal secretory products of 
preadipocytes (Table 1). The sole protein which was not detectable in the medium of untreated 
cells was IL-10. Very low levels (<1 pg/ml) of IL-4, GM-CSF and  
TNFwere evident. The most abundant proteins in the medium of the control preadipocytes 
were IL-8 and VEGF, which were present at concentration >1 ng/ml and several hundred pg/ml, 
respectively.   
 Treatment with IL-1β resulted in marked increases in the amount present in the mediumfor most 
of the cytokines and chemokines (Table 1). Although IL-10 was not produced by the control cells, 
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its production and release were induced by IL-1albeit at low levels. For some factors, 
including IL-4, IL-7, IFN and TNF, the minimal basal release was replaced by much more 
measurable quantities of the protein following IL-1β treatment. In the case of IL-6 and IL-8, the 
concentration in the medium was at the ng/ml level following exposure of the preadipocytes to 
IL-1β, with the amount of IL-8 reaching 30 ng/ml. For IL-6, this reflected a >450-fold increase 
in release from the preadipocytes; indeed, IL-1 stimulated the production and release of IL-6 
proportionately more than for any other factor (no ‘fold increase’ can be given for IL-10 as this 
cytokinewas not detected in the medium from the control cells). Two further proteins, IP-10 and 
GM-CSF, exhibited a >100-fold increase in concentration in the medium following treatment with 
IL-1 (Table 1).  
In contrast to the other proteins, the release of IL-16 and of IL-12p70 was not stimulated 
by IL-1β (Table 1).  
   
Gene expression  
The effect of IL-1 on the expression of a selected group of cytokine and chemokine genes was 
also investigatedin human preadipocytes. The genes were primarily those encoding a sample of the 
multiple proteins examined in the array studies. The mRNA measurements were made at 4 and 24 
h, to determine acute versus sustained responses to IL-1. The expression of each of the genes, 
that is the mRNA level, was very low in the control, untreated cells, the Ct values being  
33-36. There were, however, substantial increases with IL-1in the level of the mRNAs forIL7,  
CCL3, CCL11, CCL13, CXCL10 and CSF3 (Fig 1); these mRNAs encode IL-7, MIP-1α, eotaxin1, 
MCP-4, IP-10 and and G-CSF (granulocyte colony stimulating factor), respectively. In the case of 
CCL3the increase at 4 h was >1,000-fold relative to the control cells, and nearly 1,000-fold at the 
same time point for CXCL10 and CSF3. No signal was obeserved for CSF2 mRNA in the control 
cells at either 4 or 24 h, but there was a substantial induction of CSF2 expression with IL-1β at 4 
h (result not shown).  
For each of the genes, with the exception ofCCL13, the mRNA level in IL-1-treated 
preadipocytesrelative to the control cells was considerably higher at 4 h than at 24 h (Fig 1). This 
was particularly evident for CCXL10 where the nearly 1,000-fold increase in mRNA level at 4 h 
declined to <100-fold at 24 h (Fig 1).   
Further analysis of several of the genes during the development of adipocytes indicated 
that the expression of CCL13 was highly differentiation-dependent. In preadipocytes, the basal 
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expression of CCL13 was minimal, and it was only at day 4 post-induction of differentiation that 
substantial expression was evident; there was a progressive increase thereafter in CCL13 mRNA 
level with adipocyte development (Fig 2A). A similar pattern was apparent in the release into the 
medium of the encoded protein, MCP-4 (Fig 2B), the amount secreted at day 12 post-induction 
being 77-times greater than at day 0 (where it was barely detectable). The time course of IL-7 
expression and release broadly paralleled that of CCL13/MCP-4, but greater expression and 
secretion was evident before differentiation with IL-7, and as a consequence the effects of 
differentiation were less marked (results not shown); IL7 mRNA level was 6.9-fold greater and IL-
7 protein release 10.3 fold greater in adipocytes at day 12 post-induction than in preadipocytes at 
day 0. 
  
Discussion  
The recruitment and activation of macrophages is considered to be central to the establishment of 
the inflammatory state that develops in white adipose tissue in obesity (Weisberg et al., 2003; Xu et 
al., 2003). Mature adipocytes are themselves important inflammatory cells, releasing a wide range 
of cytokines and chemokines as well as other inflammation-related factors following the 
appropriate stimulus (Trayhurn et al., 2001; Rajala et al., 2004; Meijer et al., 2011; Trayhurn, 2013). 
Secretory products from macrophages have been shown to elicit an extensive inflammatory 
response in fat cells (O’Hara et al., 2009; Meijer et al., 2011) and this can be mimicked, at least in 
part, by lipopolysaccharide, TNFand IL-1β (Wang et al., 2005; Meijer et al., 2011; Alomar et al., 
2015). An inflammatory response can also be elicited in preadipocytes (Lacasa et al., 2007; 
Keophiphath et al., 2009; Gao & Bing, 2011; Meijer et al., 2011; O’Hara et al., 2012), which have 
been described as ‘macrophage-like cells’ (Cousin et al., 1999), and potentially in other cell 
typeswithin adipose depots. Inflammation in preadipocytes is activated by secretions from 
macrophages, as studies with macrophage-conditioned medium have demonstrated (Lacasa et al., 
2007; Gao & Bing, 2011; O’Hara et al., 2012). Thus there is extensive cross-talk between 
macrophages and the key cells within white fat.  
 Lipopolysaccharide, TNFα and IL-1have each been shown to induce an inflammatory 
response in preadipocytes (Lacasa et al., 2007; Gao & Bing, 2011; Meijer et al., 2011; O’Hara et al.,  
2012). In the case of IL-1 this pro-inflammatory cytokine isspecifically reported to stimulate 
the expression and secretion of IL-6 and of matrix metalloproteinases 1 and 3 (Gao & Bing, 2011; 
O’Hara et al., 2012). IL-1has been shown to inhibit adipocyte differentiation in both 3T3-L1 
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cells and human preadipocytes, but the concentration required appears much higher for the human 
cells (Simons et al., 2005; Lu et at., 2011; Gagnon et al., 2013).   
The present study demonstrates that the effects of IL-1on human preadipocytes are 
extensive, protein arrays indicating that the factor stimulates the release of multiple cytokines and 
chemokines. Of the proteins on the arrays,IL-6, IP-10 and GM-CSF were the most responsive to 
IL-1in terms of the proportional increase in production. In some cases, including TNFIL-
4 and IL-10, the basal secretion was at, or close to, the limit of detection of the arrays, but 
IL1induced the release of readily measurable quantities of these cytokines. In practise, IL-10 
was undetectable in the medium of un-stimulated preadipocytes.   
 The effects of IL-1 on preadipocytes are broadly similar to that which we recently reported for 
mature human adipocytes (Alomar et al., 2015). In adipocytes, as in preadipocytes, IL-6, GM-CSF, 
IL-10 and IP-10 were among the most responsive factors. Both IL-15 and VEGF were the least 
responsive; nevertheless, the amount of these factors released was increased 2-3-fold by IL-1β. 
The secretion of IL-16 and IL-12p40 wasnot stimulated by IL-1in either adipocytes or 
preadipocytes. The main difference evident between preadipocytes and adipocytes (with similar 
experimental protocols) is that the release of MDC and IL-2 was stimulated rather more in mature 
fat cells than in their precursors - MDC 27.7-fold versus 2.9fold, IL-2 27.9-fold versus 3.7-fold, 
for adipocytes and preadipocytes respectively (Alomar et al., 2015).  
 In terms of the absolute amount of a specific protein released into the medium by unstimulated 
cells, VEGF and IL-8 were the most abundantin both preadipocytes and adipocytes.  
In cells treated with IL-1 the quantitatively most important of the measured proteins in the 
medium from preadipocytes were IL-6 and IL-8, and these were also two of the most abundant 
secreted factors in the case of stimulated adipocytes (Alomar et al., 2015). For both types of cell, 
these proteins were present in the medium at ng levels. Thus there is a close similarity between 
mature adipocytes and preadipocytes not only in the responsiveness to IL-1 but also in the 
relative amounts of different cytokines and chemokines that are secreted. These comparisons 
assume, of course, that the secreted factors are released as such and are stable in the medium and 
not subject to significant degradation during the period that the cells are incubated. 
 We recently described MCP-4 as a novel adipokine, demonstrating release of the protein by human 
fat cells with the secretion being stimulated by IL-1(Alomar et al., 2015). MCP-4 is encoded by 
the CCL13 gene, and both CCL13 expression and the release of MCP-4 into the medium were 
observed in preadipocytes. CCL13 expression was in practise marginal in the basal state, but there 
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was a marked induction in preadipocytes treated with IL-1; this was paralleled by a substantial 
stimulation in the release of MCP-4 protein into the medium. Time-course studies during 
differentiation showed that as preadipocytes differentiate and develop into mature fat cells there 
is a progressive increase in CCL13 gene expression. This suggest that CCL13 expression is in effect 
a late marker of differentiation, similar to factors such as leptin.MCP-4, which is also known as 
chemokine (C-C motif) ligand 13,is a chemotactic factor that attracts macrophages, monocytes, T-
lymphocytes, basophils and eosinophils, and which is involved in a number of chronic 
inflammatory diseases (Mendez-Enriquez & Garcia-Zepeda, 2013).   
In contrast to the other genes examined, the expression of CCL13 did not decrease 
between 4 and 24 h of treatment with IL-1 relative to control cells; indeed there was a marginal 
increase. The response to IL-1with respect to expression of the CCL11 and of CXCL10 genes, 
in particular, showed a substantial reduction at 24 h compared with 4 h. These genes clearly 
respond acutely, though transitorily, to stimulation by IL-1 while there was a sustained response 
in the case of CCL13. The sustained effect may indicate that other factors which accumulate 
following treatment with IL-1may play a role in stimulating CCL13 expression in preadipocytes.   
  
Conclusions  
The present study demonstrates that preadipocytes are highly responsive to IL-1β, the 
proinflammatory cytokine inducing increased production of a wide range of cytokines and 
chemokines. Many of these factors, some of which are pro- and others anti- inflammatory, are also 
released by preadipocytes in the basal, un-stimulated state. There are close parallels between both 
preadipocytes and mature adipocytes in the ability with which they are able to release 
inflammation-related factors. Preadipocytes are endocrine cells, paralleling in some respects 
adipocytes themselves – although preadipocytes are generally considered not to express and release 
the signature adipocyte hormones leptin and adiponectin. Exposure to hypoxic conditionsdoes, 
however, induce the expression and secretion of leptin by these precursor cells(Wang et al., 2008). 
Cross-talk between macrophages and preadipocytes, in addition to that between the immune cells 
and adipocytes, is likely to be a component of the inflammatory condition that is initiated in white 
adipose depots in obesity. 
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Table 1. Effect of IL-1β on cytokine and chemokine secretion from human white preadipocytes 
in culture  
  
Protein  Control 
(pg/ml)  
IL-1β treated 
(pg/ml)  
Fold-change with IL-1β  
        
IL-10  ND  2.53+0.23  -  
IL-6  7.71+0.91  3,491+66***  452.8  
IP-10  23.6+3.7  2,862+253***  121.3  
GM-CSF  0.884+0.294  100+ 4***  113.5  
MIP-1β  6.32+0.83  574+99**  90.9  
IL-13  2.82+0.19     150 + 20***  53.3  
TNFα  0.492+0.129  15.2+1.1***  30.9  
IL-8  1,049+207  30,244+4,183***  28.8  
IL12-p70  0.241+0.053  4.28+0.41***  17.8  
MCP-4  4.93+0.83  86.7+12.9***  17.6  
1FNγ  1.26+0.27  20.2 +1.5***  16.0  
Eotaxin  10.1 +0.8  135+44*  13.5  
IL-7  1.69+0.13  20.3 +1.7***  12.0  
IL-4  0.229+0.044  2.01+0.16***  8.78  
Eotaxin-3  10.2 ±1.6  55.7±11.9*  5.47  
IL-2  11.6+0.7  42.7 +2.4***  3.69  
MDC  24.3 +4.8  70.6 +3.2***  2.91  
IL-15  9.13+0.63  19.9 +0.38***  2.17  
VEGF  301 +24  620 +59 **  2.06  
        
IL-12p40  2.83+0.51  3.07+0.40NS  1.08  
IL-16  53.9+11.0  45.7 +5.2NS  0.848  
  
  
Human preadipocytes were incubated in the presence or absence of human recombinant IL-1β (2 
ng/ml). Protein arrays were used to screen the effect of IL-1β on cytokine and chemokine secretion 
into the medium over 24 h. The results (pg/ml medium) are the means + SE for 5-6 groups of 
adipocytes. ***P<0.0001, **P<0.001, *P<0.02 compared with control, untreated cells.  
NS, not significant (P>0.05). The lowest detection limit was for IL-8 (0.01 pg/ml).  
    
  
Legends to Figures   
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Figure 1. Effect of IL-1β on the expression of cytokine and chemokine genes in human 
preadipocytes. Human preadipocytes were incubated in the presence or absence of human 
recombinant IL-1β (2 ng/ml) for 4 or 24 h. The results show the fold-changes in mRNA level for 
preadipocytes treated with IL-1β compared with controls (controls normalised to 1.0) at each time 
point. No signal was detected for CSF3 in the control cells at 24 h so the IL-1β treated cells  have 
been related to the controls at 4 h. The fold-changes are mean values+ SE (bars) for 4-6 
experiments at both time points. ***P<0.0001, **P<0.001, compared with control, untreated 
cells.The proteins encoded by each of the genes examined were: CCL3, MIP-1; CC11, eotaxin; 
CCL13, MCP-4; CXCL10, IP-10; CSF3, granulocyte colony stimulating factor.  
  
Figure 2. Expression of theCCL13 gene (A)and release of the encoded MCP-4 protein (B) during 
the differentiation of human preadipocytes into adipocytes. Differentiation was induced at day 0 
and cells and medium taken every 2 days; from day 4, the cells contained multiple lipid droplets 
and stained positively with Oil red O. The results, which are expressed relative to the values at day 
0 (set as 1.0), are mean values + SE (bars) for 3-4 experiments at each time point.  
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